Literature DB >> 28444296

Challenging the myths of cardiac amyloidosis.

Omar K Siddiqi1,2, Frederick L Ruberg1,2,3.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28444296     DOI： 10.1093/eurheartj/ehx210

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  4 in total

Review 1.  Advances in Treatment of Cardiac Amyloid.

Authors:  Cherie N Dahm; R Frank Cornell; Daniel J Lenihan
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-04-07

Review 2.  Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment.

Authors:  Omar K Siddiqi; Frederick L Ruberg
Journal:  Trends Cardiovasc Med       Date:  2017-07-13       Impact factor: 6.677

3.  Diffusion Tensor Cardiovascular Magnetic Resonance in Cardiac Amyloidosis.

Authors:  David N Firmin; Dudley J Pennell; Zohya Khalique; Pedro F Ferreira; Andrew D Scott; Sonia Nielles-Vallespin; Ana Martinez-Naharro; Marianna Fontana; Phillip Hawkins
Journal:  Circ Cardiovasc Imaging       Date:  2020-05-15       Impact factor: 7.792

Review 4.  Wild-type transthyretin cardiac amyloidosis (ATTRwt-CA), previously known as senile cardiac amyloidosis: clinical presentation, diagnosis, management and emerging therapies.

Authors:  Ilia G Halatchev; Jingsheng Zheng; Jiafu Ou
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.